Global Cryoablation Devices Market 2017-2021

  • ID: 4328328
  • Report
  • Region: Global
  • 82 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • ACS Myanmar Medical
  • BVM Medical
  • CPSI Biotech
  • Galil Medical
  • ICECURE MEDICAL
  • Medtronic
  • MORE
About Cryoablation Devices

Cryoablation is a process that uses extreme cold to destroy diseased tissue. It employs a cryogenic material, such as liquid nitrogen, to freeze cancer cells. It is considered as an effective treatment modality for prostate cancer (transrectal ultrasound is used to guide hollow probes/needles that are inserted through the anus to the prostate) and is also used for the treatment of other cancers of the bone, cervix, lungs, and liver.

The analysts forecast the global cryoablation devices market to grow at a CAGR of 6.10% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global cryoablation devices market for 2017-2021. To calculate the market size, the report considers revenue generated from the sales, volume, and value of cryoablation devices.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Cryoablation Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Medtronic
  • Galil Medical
  • CooperSurgical
Other prominent vendors
  • ACS Myanmar Medical
  • AtriCure
  • BVM Medical
  • CPSI Biotech
  • ForTec Medical
  • HealthTronics
  • IRANBEHDASHT
  • ICECURE MEDICAL
  • METRUM CRYOFLEX
  • RA Distribution
  • Solution Medical
Market drivers
  • Safe and effective treatment for AVNRT patients
  • For a full, detailed list, view the full report
Market challenges
  • High cost of cryoablation devices and procedures
  • For a full, detailed list, view the full report
Market trends
  • Paradigm shift toward minimally invasive procedures
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • ACS Myanmar Medical
  • BVM Medical
  • CPSI Biotech
  • Galil Medical
  • ICECURE MEDICAL
  • Medtronic
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Market outline
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by product
  • Market overview
  • Cryoablation systems
  • Catheters and accessories
PART 07: Market segmentation by end-user
  • Market overview
  • Hospitals and specialty clinics
  • ASCs
PART 08: Geographical segmentation
  • Market overview
  • Cryoablation devices market in Americas
  • Cryoablation devices market in EMEA
  • Cryoablation devices market in APAC
PART 09: Decision framework

PART 10: Drivers and challenges
  • Market drivers
  • Market challenges
PART 11: Market trends
  • Market growth through M&A
  • Paradigm shift toward minimally invasive procedures
  • Developing countries to emerge as growth engines for cryoablation devices market
PART 12: Vendor landscape
  • Competitive landscape
PART 13: Key vendor analysis
  • Medtronic
  • Galil Medical
  • CooperSurgical
  • Other prominent vendors
PART 14: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Market flow of global cryoablation devices in 2016
Exhibit 02: Overview of global cryoablation devices market 2016
Exhibit 03: Global cryoablation devices market 2016-2021 ($ millions)
Exhibit 04: Five forces analysis
Exhibit 05: Global cryoablation devices market by product
Exhibit 06: Global cryoablation systems: Market overview
Exhibit 07: Global cryoablation systems market 2016-2021 ($ millions)
Exhibit 08: Global cryoablation catheters and accessories: Market overview
Exhibit 09: Global cryoablation catheters and accessories market 2016-2021 ($ millions)
Exhibit 10: Global cryoablation devices market by end-users 2016
Exhibit 11: Strategic analysis of global cryoablation devices market by end-users 2016
Exhibit 12: Buying criteria analysis: Global cryoablation devices market 2016
Exhibit 13: Global cryoablation devices market by geographical segmentation 2016 ($ millions)
Exhibit 14: Cryoablation devices market in Americas 2016-2021 ($ millions)
Exhibit 15: Cryoablation devices market in EMEA 2016-2021 ($ millions)
Exhibit 16: Cryoablation devices market in APAC 2016-2021 ($ millions)
Exhibit 17: Cost comparison of AF treatment by RF ablation and cryoablation procedures
Exhibit 18: Product recalls due to regulatory aspects
Exhibit 19: Percentage of cancer deaths among men and women in OECD member countries 2013
Exhibit 20: Competitive structure analysis of global cryoablation devices market 2016
Exhibit 21: Market penetration of vendors in global cryoablation devices market 2016
Exhibit 22: Strategic success factors of companies in global cryoablation devices market 2016
Exhibit 23: Medtronic: Key highlights
Exhibit 24: Medtronic: Strength assessment
Exhibit 25: Medtronic: Strategy assessment
Exhibit 26: Medtronic: Opportunity assessment
Exhibit 27: Galil Medical: Key highlights
Exhibit 28: Galil Medical: Strength assessment
Exhibit 29: Galil Medical: Strategy assessment
Exhibit 30: Galil Medical: Opportunity assessment
Exhibit 31: CooperSurgical: Key highlights
Exhibit 32: CooperSurgical: Strength assessment
Exhibit 33: CooperSurgical: Strategy assessment
Exhibit 34: CooperSurgical: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • ACS Myanmar Medical
  • BVM Medical
  • CPSI Biotech
  • Galil Medical
  • ICECURE MEDICAL
  • Medtronic
  • MORE
New Report Released: - Global Cryoablation Devices Market 2017-2021

The author of the report recognizes the following companies as the key players in the global cryoablation devices market: Medtronic, Galil Medical, and CooperSurgical.

Other Prominent Vendors in the market are: ACS Myanmar Medical, AtriCure, BVM Medical, CPSI Biotech, ForTec Medical, HealthTronics, IRANBEHDASHT, ICECURE MEDICAL, METRUM CRYOFLEX, RA Distribution, and Solution Medical.

Commenting on the report, an analyst from the research team said: “One trend in the market is paradigm shift toward minimally invasive procedures. Cryoablation is considered as one of the effective and minimally invasive procedures, which uses frigid temperatures to kill cancer cells while preserving the surrounding tissues. According to reports published by Galil Medical, doctors all over the world have been using cryoablation to treat different types of cancer.”

According to the report, one driver in the market is safe and effective treatment for AVNRT patients. AVNRT is the second most common form of paroxysmal recurrent tachycardia in children. RA ablation has become the first-line therapy for AVNRT, with high success and low recurrence rates. However, a definite risk of damage to the atrioventricular (AV) node still exists. Cryoablation procedure provides a distinct advantage adjacent to the AV node for para-Hisian pathways and difficult cases of AVNRT, which cannot be performed by conventional RA ablation.

Further, the report states that one challenge in the market is high cost of cryoablation devices and procedures. The cost of cryosurgeries involving cryoablation devices is more than that of the RF procedures. AF ablation requires the use of expensive technology and equipment. Physicians have considerable latitude in equipment choice. The average Medicare reimbursement is $10,338 for uncomplicated AF ablations. The treatment of cardiac arrhythmia can be resolved either by the RF ablation or by the cryoablation procedure.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Medtronic
  • Galil Medical
  • CooperSurgical
  • ACS Myanmar Medical
  • AtriCure
  • BVM Medical
  • CPSI Biotech
  • ForTec Medical
  • HealthTronics
  • IRANBEHDASHT
  • ICECURE MEDICAL
  • METRUM CRYOFLEX
  • RA Distribution
  • Solution Medical
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll